CMHC 2014 Symposium: Optimizing Antihypertensive Therapies in High-Risk and Difficult-to-Treat Patients

Despite well-established risks, hypertension remains undertreated and, when treated, often stubbornly difficult to control. This webcast seeks to improve guideline adherence and help clinicians integrate antihypertensive therapies into the management of high-risk patient populations including the elderly, African Americans, and patients suffering from heart failure, obesity, and diabetes.

Supported by an educational grant from Forest Laboratories, Inc.

Hypertension Guidelines Update: Current Controversies and Clinical Implications

Faculty: Michael A. Weber, MD

Pharmacology of Beta Blockers and the Role of Nitric Oxide in Vasodilation

Faculty: Keith C. Ferdinand, MD, FACC, FAHA

Combination Antihypertensive Therapy: Today's Options, Tomorrow's Possibilities

Faculty: George L. Bakris, MD

Complex Cases in Hypertension: Optimizing Antihypertensive Therapy in Difficult-to-Treat Patients

Faculty: Thomas D. Giles, MD

Panel Discussion/Q&A

Moderator: George L. Bakris, MD

Discussants: Michael A. Weber, MDKeith C. Ferdinand, MD, FACC, FAHAThomas D. Giles, MD